Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of decitabine- and RG3039-treated WT HL-60 cells

ABSTRACT: We performed stranded RNA-seq on HL-60 cells treated with decitabine for 6 hours, 72 hours and 120 hours in duplicate.

ORGANISM(S): Homo sapiens

PROVIDER: GSE222823 | GEO | 2023/01/13

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Time-series RNA-seq of decitabine-treated WT HL-60 cells

Project description:We performed stranded RNA-seq on HL-60 cells treated with decitabine for 6 hours, 72 hours and 120 hours in duplicate.

2023-01-13 | GSE222821 | GEO

MeRIP-seq of decitabine-treated WT HL-60 cells

Project description:MeRIP-seq of decitabine-treated WT HL-60 cells

| PRJNA923628 | ENA

Ribo-seq of decitabine-treated WT HL-60 cells

Project description:Ribo-seq of decitabine-treated WT HL-60 cells

| PRJNA923627 | ENA

RNA-seq of decitabine- and RG3039-treated WT HL-60 cells

Project description:RNA-seq of decitabine- and RG3039-treated WT HL-60 cells

| PRJNA923629 | ENA

Time-series RNA-seq of decitabine-treated WT HL-60 cells

Project description:Time-series RNA-seq of decitabine-treated WT HL-60 cells

| PRJNA923631 | ENA

Staphylococcus aureus lipoteichoic acid-stimulated undifferentiated and neutrophil-like differentiated HL-60 cells

Project description:HL-60 is a human promyelocytic leukemia cell line and differentiated HL-60 is an alternative to human primary neutrophils. The transcriptomic profile of undifferentiated HL-60 and dimethyl sulfoxide-differentiated HL-60 were determined at 4 and 24 hours after stimulation with high and low concentrations of Staphylococcus aureus lipoteichoic acids.

2023-12-15 | GSE239859 | GEO

RNA seq of HL-60 cells in untreated, ATRA (All- trans retinoic acid) and Vitamin D3 treated conditions

Project description:The leukemic cell line HL-60 is widely used to study normal and aberrant myelopoiesis. HL-60 cells can be treated with ATRA (all-trans retinoic acid) and Vit-D3 (1,25-Dihydroxyvitamin D3, calcitriol) to differentiate into granulocytes and monocytes respectively. Induced myeloid differentiation helps us to understand the molecular basis of myeloid differentiation. To understand the genome-wide gene expression changes associated with HL-60 cells upon myeloid differentiation, RNA-sequencing was carried out. We subjected the HL-60 cells with 10 µM ATRA and 50 nM Vit-D3 for 72 hours. Post induction, the uninduced and induced cells were sorted based on CD11b and CD14 markers. The uninduced cells were negative for both the markers while ATRA and Vit D3 inductions were highly positive for CD11b-FITC and CD14-APC-H7 markers respectively. Two biological replicates were used for this experiment. Sorted cells were collected for RNA extraction using RNAeasy Kit from Qiagen and RNA quality was assessed using Bioanalyzer. High quality RNA with RIN values greater than 8, were used to generate library using TrueSeq stranded library preparation kit from Illumina following manufacturer’s instructions. Finally, barcoded libraries were pooled, and a final concentration of 10 nM was loaded in HiSeq 2500 Illumina platform and paired-end sequencing for 2*126 cycles were carried out.

2023-01-25 | E-MTAB-12267 | biostudies-arrayexpress

HL-60 treated with TPA

Project description:Comparing the difference between TPA stimulated HL-60 and control

2013-05-05 | GSE29620 | GEO

Epichromatin HL-60/S4

Project description:Epichromatin HL-60/S4

| PRJEB5782 | ENA

Epichromatin HL-60/S4

Project description:Characterization of epichromatin by immunoprecipitation-DNA sequencing of formaldehyde-fixed and sonicated HL-60/S4 cells.

2015-12-31 | E-MTAB-2360 | biostudies-arrayexpress